| Size & multiples | |||
| Market Cap | $2.3M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 0.14× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.09 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.44% |
| After-tax Cost of Debt | — | Synthetic credit rating | C |
| Cost of Debt · embedded (pre-tax) | — | Cost of Debt · marginal (synthetic) | 20.00% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.12 · revenue TTM $16.0M · FCF TTM —
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -105.0% | -7.8% | -34.7%–1.4% | 12 ↓weak |
| Dividend Yield | 26.3% | 1.1% | 0.2%–2.4% | 97 ↑strong |
| Net Margin | -61.1% | -21.2% | -325.3%–7.2% | 41 ↓weak |
| Operating Margin | -17.8% | -34.5% | -552.0%–8.0% | 55 ↑strong |
